If a licensing board has raised concerns about substance use, impairment, relapse, testing, or a monitoring agreement, it can feel like your career is suddenly being examined from every angle at once. For many professionals, the hardest part is not only the allegation itself. It is the uncertainty: what the board is investigating, what documents matter, whether a confidential monitoring path is available, and how a single response might affect licensure, employment, credentialing, and future disclosures.
The good news is that these cases often follow recognizable patterns. Boards, monitoring programs, employers, and treatment providers tend to focus on a similar set of issues: patient safety, current fitness to practice, compliance, documentation, and risk management. In this post you’ll learn how these cases usually unfold, what boards and monitoring programs often look for, where professionals can get tripped up, and how an attorney can help organize the response.
If you want a broader overview of how impairment-related cases are built and why monitoring terms can become so important, this plain-English breakdown of monitoring, testing, treatment, and return-to-practice conditions helps connect the big picture.
<aside> 💡 Scroll to the bottom for every post in this series.
</aside>
A board case involving substance use is rarely just about one incident. In general terms, regulators often evaluate whether there is evidence of current impairment, whether there was unsafe practice, whether the professional has acknowledged a problem, and whether future risk can be managed through treatment, testing, workplace restrictions, or probation-like monitoring. The Federation of State Medical Boards notes that medical boards may investigate complaints, hold hearings, and impose actions ranging from probation and suspension to emergency suspension when alleged impairment from alcohol or drug use presents an immediate risk to the public. FSMB’s physician discipline overview and its policy on physician illness and impairment both reflect that public-protection focus.
Boards of nursing describe a similar framework. The National Council of State Boards of Nursing explains that board action can include referral to an alternative-to-discipline program, practice monitoring, treatment-related requirements, restrictions on practice, suspension, or revocation, depending on state law and case facts. It also notes that an emergency suspension may be used when there is clear and convincing evidence that continued practice presents immediate and serious harm to the public. See NCSBN’s board action guidance.
That is part of why these matters can escalate quickly. What begins as a positive test, medication discrepancy, DUI arrest, coworker report, charting concern, or missed screen can turn into a broader review of practice history, honesty, compliance, and current fitness.
Not every “substance use” board matter is the same. One of the first things an attorney often helps with is identifying which lane the case is in.
Sometimes the board has opened a standard disciplinary investigation based on a complaint, employer report, arrest report, or patient-safety event. In those cases, the board may request records, a written response, employment information, treatment records, drug-testing records, or an evaluation.
If the allegations involve practicing while impaired, diversion, patient harm, or repeated noncompliance, the board may consider interim restrictions or an emergency suspension. That possibility often changes the pace and tone of the case.
In some professions and states, there may be a confidential or non-public pathway for eligible professionals dealing with substance use disorder. NCSBN explains that alternative-to-discipline programs are designed to promote early identification, evidence-based treatment, removal from practice when needed, and a monitored return to safe practice, while allowing the nurse to demonstrate recovery in a non-disciplinary and non-public manner where state law permits. See NCSBN’s overview of alternative-to-discipline programs.
In other cases, the core issue is not the original allegation anymore. It is whether the professional complied with a monitoring agreement. A missed drug screen, diluted sample, late paperwork, treatment discharge, work-site violation, or incomplete disclosure can create a second-generation case that is sometimes harder to resolve than the first one.